
Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure forHelicobacter pyloriinfection
Author(s) -
Ji Hyun Lim,
Dong Hoon Lee,
Seong tae Lee,
Nayoung Kim,
Young Soo Park,
Cheol Min Shin,
In Sung Song
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i46.13124
Subject(s) - medicine , helicobacter pylori , moxifloxacin , urea breath test , gastroenterology , amoxicillin , breath test , adverse effect , rabeprazole , combination therapy , surgery , antibiotics , helicobacter pylori infection , microbiology and biotechnology , biology
To assess the efficacy of moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori (H. pylori) eradication.